In the last 3 years, EW Healthcare Partners has acquired 1 company. It has also invested in 2 others.
EW Healthcare Partners’ most common sectors for investment are medical products (41%) and life science (30%). The Firm’s most common investment types include venture (62%) and growth capital (15%). In total, EW Healthcare Partners has invested in 17 US states and 6 different countries. Its largest (disclosed) acquisition occurred in 2004 when it acquired LipoSonix for $27M.
In the last 3 years, EW Healthcare Partners has exited 4 companies. The Firm’s most common exit type is trade sale (59%). EW Healthcare Partners’ largest (disclosed) exit occurred in 2012 when it sold EUSA Pharma for $680M.
Join Mergr to view EW Healthcare Partners’ full profile and discover more large private equity firms just like it.
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
Join Mergr to view the latest updates and news from Palo Alto-based EW Healthcare Partners.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.